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Background
The optimum timing of surgery in asymptomatic patients
with severe degenerative mitral regurgitation (MR) is
controversial and there are no randomised data to sepa-
rate early repair from watchful waiting. Chronic volume
overload may be a stimulus for progressive myocardial
fibrosis, which could potentially be an additional marker
for left ventricular (LV) recovery after surgery.
Methods
In total, 24 patients (mean age 62 +/- 16 years) with
degenerative moderate or severe asymptomatic MR with
no class 1 indication for surgery were recruited from a
dedicated valve clinic in a University Hospital and com-
pared with gender matched controls. All subjects under-
went cardiac MRI (1.5T Siemens Avanto) for assessment
of LV volumes, deformation (SPAMM tagging), late
gadolinium enhancement (LE) and T1-mapping using a
modified look-locker inversion recovery sequence
(MOLLI) before and 15 minutes post gadolinium (0.1
mmol/Kg) for myocardial extracellular volume (ECV).
Global ECV was the average measure from basal and mid
short axis slices excluding LGE indicative of infarcted
myocardium.
Results
Patients with MR (mean regurgitant volume 42 ml ± 20)
had impaired longitudinal and circumferential systolic
deformation (Table 1) and increased global ECV (Figure 1).
These changes preceded a difference in LV ejection frac-
tion, MAPSE (Table 1) or increase in NT-proBNP (median
85 ng/L IQR 280). Global ECV was inversely correlated
with Vo2 max (r = - 0.771, p < 0.05). Nine patients had
patchy diffuse LE in non-coronary artery territories primar-
ily within the basal segments with an increased ECV com-
pared to remote “normal” myocardium.
Conclusions
Patients with MR demonstrate a spectrum of myocardial
fibrosis associated with reduced longitudinal and cir-
cumferential deformation and reduced peak VO2 max.
These changes occur before changes in conventional
markers of LV structure and function or an increase in
BNP. The routine use of CMR may provide a rationale
for improved risk stratification in patients with asympto-
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Table 1 CMR parameters of structure and function
MR Healthy
controls
LVEDV (ml/m2) 89 (18) 65 (12)*
LVESV (ml/m2) 28 (7) 20 (6)
LV mass index (g/m2) 68 (13) 57 (13)
LVEF (%) 70 (9) 72 (6)
MAPSE (mm) 14 (5) 16 (3)
Peak longitudinal systolic strain (%) 12.0 (3.3) 18.5 (5.0)*
Peak longitudinal systolic strain rate (s-1) 0.60
(0.14)
1.04 (0.42)*
Peak basal circumferential strain (%) 10.9 (3.3) 15.5 (3.1)*
Peak basal circumferential strain rate (s-1) 0.63 (0.2) 0.8 (0.1)*
Peak mid circumferential strain (%) 15.2 (5.0) 18.1 (2.4)
Peak mid circumferential strain rate (s-1) 0.8 (0.2) 1.0 (0.2)*
Data = mean (SD), *p < 0.05
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Figure 1 Global extraceullar volime in patients with moderate-severe degenerative mitral regurgitation and controls.
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